Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New agents for hypercholesterolemia designed in Japan

July 2, 2012

German company discloses new muteins of human lipocalin

July 2, 2012

OSI Pharmaceuticals divulges novel focal adhesion kinase inhibitors

July 2, 2012

New S1P1 receptor ligands presented by researchers at Allergan

July 2, 2012

Novel potential cancer immunotherapy designed in Korea

June 29, 2012

New notum-directed antibodies may be useful to treat osteoporosis

June 29, 2012

Research at Pfizer yields novel potential antibacterial drugs

June 29, 2012

Lilly presents novel MAP kinase p38 inhibitors

June 29, 2012

New formylpeptide receptor ligands patented by Allergan

June 29, 2012

Novel PARP inhibitors developed in China

June 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...